Shai Mulinari

1.8k total citations
78 papers, 1.2k citations indexed

About

Shai Mulinari is a scholar working on Pharmacology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Shai Mulinari has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmacology, 37 papers in Economics and Econometrics and 16 papers in General Health Professions. Recurrent topics in Shai Mulinari's work include Pharmaceutical industry and healthcare (38 papers), Pharmaceutical Economics and Policy (34 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Shai Mulinari is often cited by papers focused on Pharmaceutical industry and healthcare (38 papers), Pharmaceutical Economics and Policy (34 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Shai Mulinari collaborates with scholars based in Sweden, United Kingdom and Hungary. Shai Mulinari's co-authors include Juan Merlo, Piotr Ozierański, Maria Wemrell, Udo Häcker, Andreas Vilhelmsson, Courtney Davis, Anna V. Zetterqvist, Anna Bredström, S. V. Subramanian and Raquel Pérez-Vicente and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Development.

In The Last Decade

Shai Mulinari

75 papers receiving 1.1k citations

Peers

Shai Mulinari
Kirby Lee United States
Jorge Garcés Spain
Lisa Cosgrove United States
R. Moynihan United States
Sandra Soo‐Jin Lee United States
Rachel Mills United States
Fred Charatan United States
Jeffrey R. Lacasse United States
Jennifer Ruth Fosket United States
Sarah Craig United Kingdom
Kirby Lee United States
Shai Mulinari
Citations per year, relative to Shai Mulinari Shai Mulinari (= 1×) peers Kirby Lee

Countries citing papers authored by Shai Mulinari

Since Specialization
Citations

This map shows the geographic impact of Shai Mulinari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shai Mulinari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shai Mulinari more than expected).

Fields of papers citing papers by Shai Mulinari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shai Mulinari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shai Mulinari. The network helps show where Shai Mulinari may publish in the future.

Co-authorship network of co-authors of Shai Mulinari

This figure shows the co-authorship network connecting the top 25 collaborators of Shai Mulinari. A scholar is included among the top collaborators of Shai Mulinari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shai Mulinari. Shai Mulinari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moriarty, Frank, et al.. (2024). Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals. Clinical and Translational Science. 17(7). e13879–e13879. 2 indexed citations
2.
3.
Mulinari, Shai & Anna Bredström. (2023). Race in clinical trials in Sweden: How regulatory and medical standards in clinical research trump the post‐racial discourse. Sociology of Health & Illness. 46(2). 315–332. 4 indexed citations
4.
Mulinari, Shai, et al.. (2022). The making of a Swedish strategy: How organizational culture shaped the Public Health Agency's pandemic response. SHILAP Revista de lepidopterología. 2. 100082–100082. 9 indexed citations
5.
Ozierański, Piotr, et al.. (2021). A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding. Sociology of Health & Illness. 44(1). 188–210. 11 indexed citations
6.
7.
Ozierański, Piotr, et al.. (2020). Underreporting of drug industry payments to patient organisations in the UK (2012-2016). Pure (University of Bath). 1 indexed citations
8.
9.
Ozierański, Piotr, et al.. (2019). Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK. Health Policy. 123(12). 1244–1250. 18 indexed citations
10.
Cohen, Deborah, Shai Mulinari, & Piotr Ozierański. (2019). The whistleblowing drama behind Astellas’s suspension from the ABPI. BMJ. 366. l4353–l4353. 5 indexed citations
11.
12.
Fabbri, Alice, et al.. (2018). Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries. International Journal of Health Policy and Management. 7(6). 504–509. 62 indexed citations
13.
Pérez-Vicente, Raquel, et al.. (2018). Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data. Clinical Epidemiology. Volume 10. 1657–1665. 10 indexed citations
14.
15.
Mulinari, Shai, Anna Bredström, & Juan Merlo. (2015). Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden. European Journal of Public Health. 25(6). 911–917. 24 indexed citations
16.
Mulinari, Shai, Sol Juárez, Philippe Wagner, & Juan Merlo. (2015). Does Maternal Country of Birth Matter for Understanding Offspring’s Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden. PLoS ONE. 10(5). e0129362–e0129362. 11 indexed citations
17.
Mulinari, Shai. (2014). The specificity triad: notions of disease and therapeutic specificity in biomedical reasoning. Philosophy Ethics and Humanities in Medicine. 9(1). 14–14. 10 indexed citations
18.
Merlo, Juan, Philippe Wagner, Sol Juárez, Shai Mulinari, & Bo Hedblad. (2013). The tyranny of the averages and the indiscriminate use of risk factors and population attributable fractions in Public Health: the case of coronary heart disease. 5 indexed citations
19.
Zetterqvist, Anna V. & Shai Mulinari. (2013). Misleading Advertising for Antidepressants in Sweden: A Failure of Pharmaceutical Industry Self-Regulation. PLoS ONE. 8(5). e62609–e62609. 17 indexed citations
20.
Mulinari, Shai, et al.. (2008). DRhoGEF2andDiaphanousRegulate Contractile Force during Segmental Groove Morphogenesis in theDrosophilaEmbryo. Molecular Biology of the Cell. 19(5). 1883–1892. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirby Lee Breakdown of academic impact, for papers by Jorge Garcés Breakdown of academic impact, for papers by Lisa Cosgrove Breakdown of academic impact, for papers by R. Moynihan Breakdown of academic impact, for papers by Sandra Soo‐Jin Lee Breakdown of academic impact, for papers by Rachel Mills Breakdown of academic impact, for papers by Fred Charatan Breakdown of academic impact, for papers by Jeffrey R. Lacasse Breakdown of academic impact, for papers by Jennifer Ruth Fosket Breakdown of academic impact, for papers by Sarah Craig
Rankless by CCL
2026